AAISG 2024 Annual Meeting
The Allergy, Asthma, and Immunology Society of Georgia's 2024 Meeting offers Allergists/Immunologists the opportunity to learn new techniques and treatments to provide better patient care using the saftest, most proven therapies presented by leaders in their field. AAISG also seeks to provide assistance in practice management to aid in the care of patients.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and the Allergy Asthma & Immunology Society of Georgia (AAISG). The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 8 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
Practicing allergists
Primary care physicians
Allied healthcare professionals
Learning Objectives
At the conclusion of this Activity learners should be able to…
1. Identify patients where genetic testing is indicated.
2. Interpret the results of genetic testing.
3. Choose the appropriate biologic therapy for allergic and immunologic diseases.
4. Manage the patient who previously has recovered from COVID infection.
2024 Allergy, Asthma & Immunology Society of Georgia Meeting Agenda
Friday, May 3, 2024
6:00 pm – 7:00 pm Cocktails and Registration (non-CME)
7:00 pm – 8:00 pm Betty Wray Lecture and Dinner: Asthma and Biotherapeutics, Lanny Rosenwasser, MD
8:00 pm – 9:00 pm Social Networking Time (non-CME)
Saturday, May 4, 2024
7:00 am – 8:00 am Breakfast (Non-CME)
8:00 am – 9:00 am Biotherapeutics and Anti-Cytokines in Allergic Disease, Lanny Rosenwasser, MD
9:00 am – 9:20 am Food Protein-Induced Enterocolitis to Peanut, Jessica Feng, MD, MPH
9:20 am – 9:40 am Persistent Hypogammaglobulinemia Following Rituximab in a Cohort of Pediatric Patients, Jennifer Xu, MD
9:40 am – 10:00 am Break (non-CME)
10:00 am – 11:00 am Food Allergy 2024: Where Do We Go From Here Part 1, Christine Ciaccio, MD
11:00 am – 12:00 pm Food Allergy 2024: Where Do We Go From Here Part 2, Christine Ciaccio, MD
12:00 pm – 12:30 pm GINA Guideline Updates (Brief Overview from ACAAI), Kathleen May, MD
12:30 pm – 1:00 pm Business Meeting (All members encouraged to attend) (non-CME)
12:30 pm – 1:30 pm Lunch (non-CME)
7:30 pm – 10:00 pm Dinner and Entertainment (non-CME)
Sunday, May 5, 2024
7:00 am – 8:00 am Breakfast (non-CME)
8:00 am – 9:00 am Buy and Bill for Biologics: The Risks and Rewards, Jennifer Kuehn, CPC
9:00 am – 9:20 am A Case of Sever Eczema, Amanda Hall, MD
9:20 am – 9:40 am An Adolescent with Hypereosinophilia, Tyesha Coleman
9:40 am – 10:00 am Break (non-CME)
10:00 am – 11:00 am Putting the AI in A/I, Sakina Bajowala, MD
11:00 am – 11:30 am Lunch (non-CME)
11:30 am – 12:30 pm (non-CME Presentation)
12:30pm Adjourn
All identified relevant financial relationships with ineligible companies have been mitigated.
Christina Ciaccio, MD, Speaker
Consultant: Clostrabio, Siolta
Stocks/Stock Options: Clostrabio, Siolta
Advisor: Genentech
Speaker: Genentech
Sakina Bajowala, MD, Speaker
Advisor - Novartis, ARS Pharma
Ownership Interest: Wise Prince, LLC
The following have no relevant financial relationships with ineligible companies to disclose:
Rodney Johnson, MD, Planner
Julie Ellerbee, Planner
Amanda Hall, MD, Speaker
Jessica Feng, MD, Speaker
Jennifer Kuehn, Speaker
Kathleen May, MD, Speaker
Jennifer Xu, MD, Speaker
Lanny Rosenwasser, MD, Speaker
Tyesha Coleman, MD, Speaker
Available Credit
- 8.00 AMA PRA Category 1 Credit™
- 8.00 Attendance